DUBLIN–(BUSINESS WIRE)–The “Global Infectious Respiratory Disease Diagnostics Market Size, Share & Industry Trends Analysis Report by Product Type, Application, Sample Type, Technology, End-use, Regional Outlook and Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering.
The Global Infectious Respiratory Disease Diagnostics Market size is expected to reach $37.2 billion by 2028, rising at a market growth of -5.2% CAGR during the forecast period.
Infectious respiratory disorders like tuberculosis and pneumonia are becoming more common, diagnostic technology is improving, and significant companies, the government, and charitable groups are investing more in R&D for diagnostic testing. Additionally, increased number of product launches along with increased demand for tests and consumables during the pandemic. These are the main reasons that will drive the market.
Rapid technology improvements are anticipated to have a significant impact on this market by enabling accurate findings, portability, and cost-effectiveness. Due to the comparable symptoms of RSV, COVID-19, and influenza, major players are investing in the R&D and commercialization of multiplex tests for their use in the simultaneous diagnosis of these illnesses. Multiplex testing makes it possible to target numerous genes at once, cutting down on the time and expense associated with performing traditional PCR. Self-testing and point-of-care solutions are becoming more widely used, which might help the market develop even more.
Market Growth Factors
Increase in Aged Population
The proportion of elderly people in the population is rising in almost every nation on earth. Around 703 million people around the world were 65 or older in 2019. By 2050, there would be 1.5 billion older people in the world, a more than double increase. One of the main drivers of the growth of the market for respiratory disease testing and diagnostics is the increase in the world’s geriatric population. A large number of old age people are suffering from diseases such as TB. Also, the pulmonary disease is now one of the most common causes of death worldwide.
An Increase in Healthcare Facility Investment
Rising investment in research & development, particularly in developed and developing economies, will further open up lucrative market expansion opportunities for medical instruments and devices. One another significant factor promoting the growth of the market is the increased focus on improving the state of healthcare facilities and the infrastructure for healthcare as a whole. The public-private partnerships and strategic collaborations for the purpose of funding and implementing new and improved technology has been increased over the past few years.
Market Restraining Factors
Cross-Contamination Dangers and a Lack of Qualified Medical Personnel
Due to the concentration of patients with lung diseases, the potential for coughing, and the formation of droplets around pulmonary function test procedures, pulmonary function testing could be a route for the transmission of infection. These systems include laboratory-grade tubing, rebreathing valves, and mouthpieces. The most frequent source of cross-infection during testing is mouthpieces. The risk of developing tuberculosis increases due to factors such as exposed surface areas, upholstery quality, air conditioning, general clutter, ideal temperature, and humidity levels.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Consumables
- Instruments
- Imaging Tests
- Respiratory Measurement Devices
- Others
- Services
By Application
- SARS/COVID 19
- Influenza
- RSV (Respiratory Syncytial Virus)
- Tuberculosis
- Streptococcus Testing
- Others
By Sample Type
- Saliva
- Anterior Nasal Region
- Blood
- Nasopharyngeal Swabs (NPS)
- Others
By Technology
- Molecular Diagnostics
- Microbiology
- Immunoassay
- Others
By End Use
- Diagnostic Laboratories
- Hospitals
- Physician Offices & Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Becton, Dickinson and Company
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche Ltd.
- Qiagen N.V.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Quidel Corporation
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis – Global
Chapter 4. Global Infectious Respiratory Disease Diagnostics Market by Product Type
Chapter 5. Global Infectious Respiratory Disease Diagnostics Market by Application
Chapter 6. Global Infectious Respiratory Disease Diagnostics Market by Sample Type
Chapter 7. Global Infectious Respiratory Disease Diagnostics Market by Technology
Chapter 8. Global Infectious Respiratory Disease Diagnostics Market by End-use
Chapter 9. Global Infectious Respiratory Disease Diagnostics Market by Region
Chapter 10. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Becton, Dickinson and Company
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche Ltd.
- Qiagen N.V.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Quidel Corporation
For more information about this report visit https://www.researchandmarkets.com/r/qxmeft
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900